109 related articles for article (PubMed ID: 18597704)
1. Serum IL-4 as a marker of immunological response to sublingual immunotherapy.
Ciprandi G; De Amici M; Murdaca G; Colombo BM; Quaglini S; Marseglia G; Di Gioacchino M
J Biol Regul Homeost Agents; 2008; 22(2):117-23. PubMed ID: 18597704
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy provides an early increase of interferon-gamma production.
Ciprandi G; Fenoglio D; Di Gioacchino M; Ferrera A; Ferrera F; Sormani MP; Marseglia GL
J Biol Regul Homeost Agents; 2008; 22(3):169-73. PubMed ID: 18842170
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
4. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
6. Immune response to sublingual immunotherapy in children allergic to mites.
Barberi S; Villa MP; Pajno GB; La Penna F; Barreto M; Cardelli P; Amodeo R; Tabacco F; Caminiti L; Ciprandi G
J Biol Regul Homeost Agents; 2011; 25(4):627-34. PubMed ID: 22217994
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
8. Two year sublingual immunotherapy affects serum leptin.
Ciprandi G; De Amici M; Tosca M; Negrini S; Murdaca G; Marseglia GL
Int Immunopharmacol; 2009 Sep; 9(10):1244-6. PubMed ID: 19497390
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta and IL-17 serum levels and specific immunotherapy.
Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
[TBL] [Abstract][Full Text] [Related]
10. Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4.
Piconi S; Trabattoni D; Rainone V; Borgonovo L; Passerini S; Rizzardini G; Frati F; Iemoli E; Clerici M
J Immunol; 2010 Dec; 185(12):7723-30. PubMed ID: 21076061
[TBL] [Abstract][Full Text] [Related]
11. Carry-over effect on IFN-gamma production induced by allergen-specific immunotherapy.
Ciprandi G; Sormani MP; Filaci G; Fenoglio D
Int Immunopharmacol; 2008 Dec; 8(12):1622-5. PubMed ID: 18691675
[TBL] [Abstract][Full Text] [Related]
12. Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports.
Ciprandi G; Cirillo I; Fenoglio D; Marseglia G; Tosca MA
Int Immunopharmacol; 2006 Aug; 6(8):1370-3. PubMed ID: 16782551
[TBL] [Abstract][Full Text] [Related]
13. Adipokines and sublingual immunotherapy: preliminary report.
Ciprandi G; De Amici M; Murdaca G; Filaci G; Fenoglio D; Marseglia GL
Hum Immunol; 2009 Jan; 70(1):73-8. PubMed ID: 19028536
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.
Brimnes J; Kildsgaard J; Jacobi H; Lund K
Clin Exp Allergy; 2007 Apr; 37(4):488-97. PubMed ID: 17430344
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis.
Ciprandi G; De Amici M; Tosca MA; Pistorio A; Marseglia GL
Int J Immunopathol Pharmacol; 2009; 22(4):1089-96. PubMed ID: 20074473
[TBL] [Abstract][Full Text] [Related]
16. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study.
Mauro M; Russello M; Incorvaia C; Gazzola GB; Di Cara G; Frati F
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):119-22. PubMed ID: 17523385
[TBL] [Abstract][Full Text] [Related]
18. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
19. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
20. Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells.
Glück J; Rogala B; Rogala E; Oleś E
Vaccine; 2007 Dec; 26(1):77-81. PubMed ID: 18054415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
